28
Filings
28
Companies
0
Signals Fired
Executive Educational Background Disclosure
Top Signal
Form: Date: 09/18 09/17 09/16 09/15 09/14 09/11 09/10
LFUS LITTELFUSE INC /DE 8-K Sep 16 Explore →
Other
Section 409A Compliance Statement Executive Transition Gratitude Statement Share Withholding Tax Settlement Non Solicitation Covenant
SXC SunCoke Energy, Inc. 8-K Sep 16 Explore →
Other
Executive Educational Background Disclosure Board Committee Composition Disclosure Employee Director Compensation Waiver Executive Transition Gratitude Statement
FCCO FIRST COMMUNITY CORP /SC/ 8-K Sep 16 Explore →
Other
Executive Educational Background Disclosure Director Continuity Stated
MBBC Marathon Bancorp, Inc. /MD/ 10-K Sep 16 Explore →
Other
Burn Rate Controlled Warrant Valued Black Scholes Quarterly Tax Provision Benefit Disclosure Quarterly Loan Deposit Growth Comparison Share Repurchase Activity Disclosed Deferred Tax Asset Valuation Disclosure Depreciation Expense Composition Disclosure Lease Rou Incremental Borrowing Rate Disclosure Net Loss Reported Codm Segment Reporting Disclosure Allowance For Loan Losses Disclosure Credit Loss Provision Financing Activities Cash Flow Disclosure Effective Tax Rate Reconciliation Allowance For Credit Losses Methodology Disclosed
SNDR Schneider National, Inc. 8-K Sep 16 Explore →
Other
Sanctions Compliance Representation Restrictive Debt Covenants Disclosure Borrower Fee Payment Obligation Hazardous Materials Definition Prime Rate Determination Methodology Fcpa Compliance Representation Libor Based Term Loan Pricing Successor Agent Appointment Provision Confidential Information Return Obligation Sofr Benchmark Transition Definition Erisa Definition Or Compliance Statement No Regulatory Approval Required Epa Environmental Regulation Disclosure Closing Logistics Specified Term Loan B Holding Disclosure
MRCY MERCURY SYSTEMS INC 8-K Sep 16 Explore →
Other
Geographic Footprint Disclosure
IHT INNSUITES HOSPITALITY TRUST 10-Q Sep 16 Explore →
Healthcare
Pricing Power Services Reimbursement Improving Volume Inflecting Premium Pricing Power Utilization Improving
Other
Pricing Power Expanding Market Share Gaining Quarterly Dividend Declared Cash Flow Statement Investing Activities Depreciation Expense Composition Disclosure Related Party Loan
SaaS
Membership Growing Deal Size Increasing Usage Growth Same Client Revenue Growing
FGNX FG Nexus Inc. 8-K Sep 16 Explore →
Other
Share Repurchase Activity Disclosed
APT ALPHA PRO TECH LTD 8-K Sep 16 Explore →
Other
Auditor Appointment Ratification Auditor Change Sec Comment Letter Response
IVDN INNOVATIVE DESIGNS INC 10-Q Sep 16 Explore →
Other
Shares Outstanding Disclosure Sga Expense Comparison Disclosed Lease Rou Incremental Borrowing Rate Disclosure
MYSZ My Size, Inc. 8-K Sep 16 Explore →
Other
Use Of Proceeds Disclosure Ipo Net Proceeds Disclosure Amendment Modification Waiver Clause Fcpa Compliance Representation Sanctions Compliance Representation Exchange Offer Letter Of Transmittal Forward Looking Statement Definition Ipo Or Capital Raising Completion Confidential Information Return Obligation
XBIO Xenetic Biosciences, Inc. 8-K Sep 16 Explore →
Core
Clinical Trial Result Indication Expansion Clinical Hold Lead Asset Progress
Other
Safety Differentiated Patient Retention High Publication Positive Kol Endorsement Enrollment Ahead Of Schedule Fda Breakthrough Device Designation Fda Aligned Fast Track Designation Received Corporate Authority Representation
Healthcare
Mlr Stable
Biotech Risk
Clinical Hold Active
HIVE HIVE Digital Technologies Ltd. 8-K Sep 16 Explore →
Other
Bitcoin Technology Description Executive Educational Background Disclosure
LION Lionsgate Studios Corp. 8-K Sep 16 Explore →
Other
Auditor Appointment Ratification Quorum Presence Disclosed Say On Pay Vote Result Disclosed
OGEN ORAGENICS INC 8-K Sep 16 Explore →
Core
Clinical Trial Result Lead Asset Progress Indication Expansion Combination Therapy Mentioned
Other
Fda Aligned Patient Retention High Enrollment Ahead Of Schedule Interim Data Positive Forward Looking Statement Definition Expanded Access Program Active Protocol Amended
Biotech v3
Ind Submission Planned
XCUR EXICURE, INC. 8-K Sep 16 Explore →
Other
Nasdaq Minimum Bid Price Delisting Notice
BENF Beneficient 8-K Sep 16 Explore →
Other
Director Continuity Stated
ALKS Alkermes plc. 8-K Sep 16 Explore →
Other
Kol Endorsement Executive Educational Background Disclosure Classified Board Director Election
ALLR Allarity Therapeutics, Inc. 8-K Sep 16 Explore →
Core
Indication Expansion
Other
Fast Track Designation Received Fast Track Granted Orphan Status Granted Patent Family Portfolio Disclosure Expanded Access Program Active
KRMN Karman Holdings Inc. 8-K Sep 16 Explore →
SaaS
Efficient Growth Backlog Building
Healthcare
Same Facility Growth
Other
Demand Accelerating Backlog Disclosure Adjusted Ebitda Period Comparison Merger Acquisition Synergy Benefit Claim Order Backlog Level
ABOS Acumen Pharmaceuticals, Inc. 8-K Sep 16 Explore →
Core
Clinical Trial Result Indication Expansion Clinical Hold Combination Therapy Mentioned
Biotech Risk
Accelerated Approval
Other
Publication Positive Patient Retention High Fast Track Designation Received Ce Mark Received Fda Aligned Safety Differentiated Fda Breakthrough Device Designation Fast Track Granted Interim Data Positive
RELI Reliance Global Group, Inc. 8-K Sep 16 Explore →
Other
Adjusted Ebitda Period Comparison Merger Acquisition Synergy Benefit Claim
PED PEDEVCO CORP 8-K Sep 16 Explore →
Other
Mineral Exploration Delineation Earnings Call Qa Segment
DFDV DeFi Development Corp. 8-K Sep 16 Explore →
Other
Quarterly Dividend Declared
BRRN Byrn, Inc. 8-K Sep 16 Explore →
Other
Nyse Listing Disclosure Reverse Stock Split Effected
YOU Clear Secure, Inc. 8-K Sep 16 Explore →
Other
Executive Transition Gratitude Statement
MYGN MYRIAD GENETICS INC 8-K Sep 16 Explore →
Core
Management Exodus
VISM VISIUM TECHNOLOGIES, INC. 8-K Sep 16 Explore →
Other
Classified Board Director Election